ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

ENTA Enanta Pharmaceuticals Inc

13,06
-0,28 (-2,10%)
16 Mai 2024 - Fermé
Retardé de 15 minutes
Quarter End Mar 2022Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 18,72M19,48M20,32M23,59M17,8M18,89M18,93M18M
Revenu d'exploitation -33,85M-32,54M-27,05M-30,01M-39,45M-36,71M-31,03M-34,89M
Revenu avant impôt -33,56M-32,15M-26,33M-29,02M-37,61M-34,84M-29,52M-34,03M
Revenu net -33,59M-31,7M-26,35M-28,99M-37,66M-39,07M-28,11M-33,41M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -33,56M-32,15M-27,05M-30,01M-39,45M-36,71M-31,03M-34,89M
EBITDA -33,03M-31,82M-26,39M-29,5M-38,91M-36,06M-30,36M-34,24M
Fin d'année 30 Septembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 88,27M102,81M206,63M205,2M122,47M97,07M86,16M79,2M
Revenu d'exploitation 30,84M24,61M88,33M36,74M-41,64M-109,57M-123,84M-137,21M
Revenu avant impôt 32,56M26,95M93,12M45,56M-35,02M-107,58M-122,19M-131M
Revenu net 21,67M17,71M71,96M46,38M-36,17M-79M-121,76M-133,82M
Dividendes privilégiés 00000000
Résultat de base par action 1.1380.9263.712.354-1.801-3.903-5.876-6.356
EBIT 30,84M24,61M88,33M36,74M-41,64M-109,57M-123,84M-137,21M
EBITDA 32,5M26,75M90,85M40M-38M-106,24M-120,87M-134,84M

Dernières Valeurs Consultées

Delayed Upgrade Clock